BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4079466)

  • 1. Studies on the comparative coronary vasodilator, vasodepressor and antiarrhythmic actions of gallopamil (D-600) and nisoldipine (Bay K 5552).
    Basu DK; Brahmankar DM
    Mater Med Pol; 1985; 17(2):103-6. PubMed ID: 4079466
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voltage clamp comparison of the organic calcium channel blockers D-600 and nisoldipine.
    Uehara A; Hume JR
    Proc West Pharmacol Soc; 1984; 27():343-7. PubMed ID: 6494173
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of vasodilating effects of nisoldipine and nifedipine in anesthetized open-chest dogs.
    Sakanashi M; Noguchi K; Kato T; Sunagawa R; Nagamine F; Nakasone J
    Arzneimittelforschung; 1986 Dec; 36(12):1736-9. PubMed ID: 3566835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nisoldipine (BAY K 5552), a new calcium antagonist. Antihypertensive effect in conscious, unrestrained renal hypertensive dogs.
    Knorr A
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):141-50. PubMed ID: 7165419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart.
    Takahashi K; Taira N
    Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular action of m-nisoldipine in anaesthetized rabbits and guinea pigs].
    Ren LM; Li YS; Fu SX; Jin CJ
    Zhongguo Yao Li Xue Bao; 1988 Sep; 9(5):426-30. PubMed ID: 3218537
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist.
    Warltier DC; Meils CM; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1981 Jul; 218(1):296-302. PubMed ID: 7248040
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of calcium channels in neuroblastoma x glioma hybrid cells by verapamil, D600, diltiazem and nisoldipine.
    Bodewei R; Hering S; Schubert B; Wollenberger A
    Biomed Biochim Acta; 1987; 46(8-9):S688-90. PubMed ID: 2449201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the novel calcium channel blocker, anipamil, on the isolated rabbit heart. Comparison with verapamil and gallopamil.
    Raddino R; Poli E; Pasini E; Ferrari R
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):339-44. PubMed ID: 1383837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: alterations in baroreflex sensitivity.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):376-82. PubMed ID: 6747841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].
    Urbaszek W; Kalkowski H; Günther K; Splith G; Trenckmann H
    Z Gesamte Inn Med; 1969 Feb; 24(4):102-8. PubMed ID: 4978753
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative electrophysiologic and coronary hemodynamic effects of diltiazem, nisoldipine and verapamil on myocardial tissue.
    Lathrop DA; Valle-Aguilera JR; Millard RW; Gaum WE; Hannon DW; Francis PD; Nakaya H; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):613-20. PubMed ID: 7058769
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological control of heart rate].
    Sirtori CR; Franceschini G
    Ann Ital Med Int; 1994 Oct; 9 Suppl():29S-35S. PubMed ID: 7857754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium-antagonist-type cardiac effects of nifedipine in vitro and in vivo. Comparative experimental study].
    Cosín J; Gimeno JV; Martín G; Ramírez A; Ferrer J; Báguena J
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II115-22. PubMed ID: 7170402
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of nisoldipine on coronary collateral perfusion and hemodynamics in chronically instrumented dogs.
    Kenny D; Hartman JC; Brooks HL; Warltier DC
    Pharmacology; 1989; 38(4):263-71. PubMed ID: 2755966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nisoldipine: a new, more selective calcium current blocker in cardiac Purkinje fibers.
    Kass RS
    J Pharmacol Exp Ther; 1982 Nov; 223(2):446-56. PubMed ID: 7150411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
    Altura BM; Altura BT
    Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nicardipine, a new dihydropyridine vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs.
    Nakaya H; Kanno M
    Arzneimittelforschung; 1982; 32(6):626-9. PubMed ID: 7202368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.